From lipid retention to immune-mediate inflammation and associated angiogenesis in the pathogenesis of atherosclerosis

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 8, 2015, Pages 739-749

  Usman, Ammara ^a   Ribatti, Domenico ^b,c   Sadat, Umar ^a   Gillard, Jonathan H ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Angiogenesis; Atherosclerosis; Inflammation; Lipid; Myocardial infarction; Plaque; Stroke

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VASCULOTROPIN;

ACUTE CORONARY DISEASE; ANGIOGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; HUMAN; HYPERPLASIA; IMMUNITY; INFLAMMATION; INTIMAL HYPERPLASIA; LIPID OXIDATION; LIPID STORAGE; MACROPHAGE; MAST CELL; MONOCYTE; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); REVIEW; THROMBOSIS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC;

ATHEROSCLEROSIS; HUMANS; LIPIDS; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC;

EID: 84940385987     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.30460     Document Type: Review

References (96)

1. WHO. Global staus report on non communicable diseases 2010. WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland 2011
2. WHO. Global atlas on cardiovascular disease prevention and control 2011. Fact sheet N°317
3. Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006; 3: e442
4. Muller JE, Abela GS, Nesto RW, Tofler GH: Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol, 1994; 23: 809-813
5. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Jr., Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation, 2003; 108: 1664-1672
6. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2000; 20: 1262-1275
7. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med, 1997; 336: 1276-1282
8. Redgrave JN, Gallagher P, Lovett JK, Rothwell PM: Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke, 2008; 39: 1722-1729
9. Nakashima Y, Wight TN, Sueishi K: Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc Res, 2008; 79: 14-23
10. Fogelstrand P, Boren J: Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis, 2012; 22: 1-7
11. Tabas I, Williams KJ, Boren J: Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation, 2007; 116: 1832-1844
12. Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA: Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival. Circulation, 2007; 116: 613-618
13. Williams KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol, 1995; 15: 551-561
14. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K: Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol, 2007; 27: 1159-1165
15. Camejo G, Lopez A, Vegas H, Paoli H: The participation of aortic proteins in the formation of complexes between low density lipoproteins and intima-media extracts. Atherosclerosis, 1975; 21: 77-91
16. Camejo G, Lalaguna F, Lopez F, Starosta R: Characterization and properties of a lipoprotein-complexing proteoglycan from human aorta. Atherosclerosis, 1980; 35: 307-320
17. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS: Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem, 1981; 256: 8234-8241
18. Nordestgaard BG, Wootton R, Lewis B: Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol, 1995; 15: 534-542
19. Simionescu N, Simionescu M: Cellular interactions of lipoproteins with the vascular endothelium: endocytosis and transcytosis. Targeted Diagn Ther, 1991; 5: 45-95
20. Camejo G: The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. Adv Lipid Res, 1982; 19: 1-53
21. Sartipy P, Camejo G, Svensson L, Hurt-Camejo E: Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans. J Biol Chem, 1999; 274: 25913-25920
22. Kugiyama K, Ota Y, Takazoe K, Moriyama Y, Kawano H, Miyao Y, Sakamoto T, Soejima H, Ogawa H, Doi H, Sugiyama S, Yasue H: Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. Circulation, 1999; 100: 1280-1284
23. Chung BH, Tallis G, Yalamoori V, Anantharamaiah GM, Segrest JP: Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arterioscler Thromb, 1994; 14: 622-635
24. Twickler T, Dallinga-Thie GM, Chapman MJ, Cohn JS: Remnant lipoproteins and atherosclerosis. Curr Atheroscler Rep, 2005; 7: 140-147
25. O’Brien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, Hudkins K, Wight TN, Chait A: Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation, 1998; 98: 519-527
26. Nakajima T, Origuchi N, Matsunaga T, Kawai S, Hokari S, Nakamura H, Inoue I, Katayama S, Nagata A, Komoda T: Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann Clin Biochem, 2000; 37 (Pt 2): 179-186
27. Thorne RF, Mhaidat NM, Ralston KJ, Burns GF: CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis. FEBS Lett, 2007; 581: 1227-1232
28. Camejo G, Hurt E, Wiklund O, Rosengren B, Lopez F, Bondjers G: Modifications of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate. Biochim Biophys Acta, 1991; 1096: 253-261
29. Mateu L, Avila EM, Camejo G, Leon V, Liscano N: The structural stability of low-density lipoprotein. A kinetic X-ray scattering study of its interaction with arterial proteoglycans. Biochim Biophys Acta, 1984; 795: 525-534
30. Hurt E, Bondjers G, Camejo G: Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J Lipid Res, 1990; 31: 443-454
31. Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Ahlstrom C, Fager G, Bondjers G: Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb, 1992; 12: 569-583
32. Upritchard JE, Sutherland WH: Oxidation of heparintreated low density lipoprotein by peroxidases. Atherosclerosis, 1999; 146: 211-219
33. Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G: Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem, 1993; 268: 14131-14137
34. Chang MY, Potter-Perigo S, Tsoi C, Chait A, Wight TN: Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem, 2000; 275: 4766-4773
35. Gustafsson M, Levin M, Skalen K, Perman J, Friden V, Jirholt P, Olofsson SO, Fazio S, Linton MF, Semenkovich CF, Olivecrona G, Boren J: Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ Res, 2007; 101: 777-783
36. Babaev VR, Fazio S, Gleaves LA, Carter KJ, Semenkovich CF, Linton MF: Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest, 1999; 103: 1697-1705
37. Wilson K, Fry GL, Chappell DA, Sigmund CD, Medh JD: Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol, 2001; 21: 1809-1815
38. Oorni K, Hakala JK, Annila A, Ala-Korpela M, Kovanen PT: Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem, 1998; 273: 29127-29134
39. Glass CK, Witztum JL: Atherosclerosis. the road ahead. Cell, 2001; 104: 503-516
40. Mestas J, Ley K: Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med, 2008; 18: 228-232
41. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S, Welch CL, Wang N, Randolph GJ, Snoeck HW, Tall AR: ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science, 2010; 328: 1689-1693
42. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C: Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med, 2009; 15: 97-103
43. Kamei M, Carman CV: New observations on the trafficking and diapedesis of monocytes. Curr Opin Hematol, 2010; 17: 43-52
44. Tabas I: Macrophage death and defective inflammation 231 resolution in atherosclerosis. Nat Rev Immunol, 2010; 10: 36-46
45. Johnson JL, Newby AC: Macrophage heterogeneity in atherosclerotic plaques. Curr Opin Lipidol, 2009; 20: 370-378
46. Hansson GK: Cell-mediated immunity in atherosclerosis. Curr Opin Lipidol, 1997; 8: 301-311
47. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet, 1993; 341: 255-259
48. Hansson GK: Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol, 2001; 21: 1876-1890
49. Zhou X, Hansson GK: Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand J Immunol, 1999; 50: 25-30
50. Hansson GK: The B cell: a good guy in vascular disease ? Arterioscler Thromb Vasc Biol, 2002; 22: 523-524
51. Liu MC, Proud D, Lichtenstein LM, MacGlashan DW Jr, Schleimer RP, Adkinson NF Jr, Kagey-Sobotka A, Schulman ES, Plaut M: Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol, 1986; 136: 2588-2595
52. Wize J, Wojtecka-Lukasik E, Maslinski S: Collagen-derived peptides release mast cell histamine. Agents Actions, 1986; 18: 262-265
53. Johnson JL, Jackson CL, Angelini GD, George SJ: Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 1998; 18: 1707-1715
54. Nakano T, Ninomiya T, Sumiyoshi S, Onimaru M, Fujii H, Itabe H, Nakashima Y, Sueishi K, Tsuruya K, Oda Y, Kitazono T, Kiyohara Y: Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: results from the Hisayama Study. Kidney Int, 2013; 84: 373-380
55. Williams JK, Armstrong ML, Heistad DD: Vasa vasorum in atherosclerotic coronary arteries: responses to vasoactive stimuli and regression of atherosclerosis. Circ Res, 1988; 62: 515-523
56. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR Jr, Schwartz RS, Lerman A: Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest, 1998; 101: 1551-1556
57. Galili O, Sattler KJ, Herrmann J, Woodrum J, Olson M, Lerman LO, Lerman A: Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries. J Thorac Cardiovasc Surg, 2005; 129: 767-772
58. Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD: Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med, 2001; 7: 425-429
59. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM: Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation, 2001; 104: 864-869
60. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, van der Wal AC, Borst C: Atherosclerotic arte rial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis, 2000; 150: 245-253
61. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP: Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol, 2008; 51: 1258-1265
62. Sluimer JC, Daemen MJ: Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol, 2009; 218: 7-29
63. Baba H, Yonemitsu Y, Nakano T, Onimaru M, Miyazaki M, Ikeda Y, Sumiyoshi S, Ueda Y, Hasegawa M, Yoshino I, Maehara Y, Sueishi K: Cytoplasmic expression and extracellular deposition of an antiangiogenic factor, pigment epithelium-derived factor, in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 2005; 25: 1938-1944
64. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y, Ishii T, Iida M, Sueishi K: Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol, 2005; 36: 330-340
65. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes J, Isner JM: Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol, 1997; 150: 1673-1685
66. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med, 2002; 8: 831-840
67. Hughes SE, Crossman D, Hall PA: Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res, 1993; 27: 1214-1219
68. Kaartinen M, Penttila A, Kovanen PT: Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation, 1994; 90: 1669-1678
69. Hansson GK, Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol, 2006; 6: 508-519
70. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J: Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol, 2005; 25: 2054-2061
71. Pepper MS: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol, 2001; 21: 1104-1117
72. Sueishi K, Yasunaga C, Castellanos E, Kumamoto M, Tanaka K: Sustained arterial injury and progression of atherosclerosis. Ann N Y Acad Sci, 1990; 598: 223-231
73. Brodsky S, Chen J, Lee A, Akassoglou K, Norman J, Goligorsky MS: Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Am J Physiol Heart Circ Physiol, 2001; 281: H1784-1792
74. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest, 1994; 94: 2493-2503
75. Levy AP, Moreno PR: Intraplaque hemorrhage. Curr Mol Med, 2006; 6: 479-488
76. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ: Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell, 1998; 95: 365-377
77. Heinecke JW: Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress. Free Radic Biol Med, 2002; 32: 1090-1101
78. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P: Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol, 2001; 158: 879-891
79. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation, 1995; 92: 657-671
80. Falk E: Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. The American journal of cardiology, 1989; 63: 114E-120E
81. Gertz SD, Roberts WC: Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol, 1990; 66: 1368-1372
82. Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the vulnerable plaque. J Am Coll Cardiol, 2006; 47: C13-18
83. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L: Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol, 1994; 23: 1562-1569
84. Loree HM, Kamm RD, Stringfellow RG, Lee RT: Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res, 1992; 71: 850-858
85. Richardson PD, Davies MJ, Born GV: Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet, 1989; 2: 941-944
86. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J, 1993; 69: 377-381
87. Hansson GK, Libby P, Schonbeck U, Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res, 2002; 91: 281-291
88. Libby P: Molecular bases of the acute coronary syndromes. Circulation, 1995; 91: 2844-2850
89. Libby P: Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol, 2000; 86: 3J-8J; discussion 8J-9J
90. Dollery CM, Owen CA, Sukhova GK, Krettek A, Shapiro SD, Libby P: Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation, 2003; 107: 2829-2836
91. Herman MP, Sukhova GK, Libby P, Gerdes N, Tang N, Horton DB, Kilbride M, Breitbart RE, Chun M, Schonbeck U: Expression of neutrophil collagenase (matrix metalloproteinase- 8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation, 2001; 104: 1899-1904
92. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P: Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation, 1999; 99: 2503-2509
93. Libby P: Changing concepts of atherogenesis. J Intern Med, 2000; 247: 349-358
94. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest, 1998; 102: 576-583
95. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res, 2002; 90: 251-262
96. Virmani R, Burke AP, Farb A, Gold HK, Finn AV, Kolodgie FD: Plaque Rupture. In: Renu Virmani JNMBLJTW, ed. The Vulnerable Atherosclerotic Plaque; 2007: 37-59